Poster Presentations -Cartilage/Chondrocyte Biology S105 genetic processes. Functional studies in primary human chondrocytes have long been hampered by the low transfection efficiencies of non-viral gene delivery methods in these cells. Only with the development of specific electroporation methods like nucleofection and radiofrequency (RF) electroporation highly efficient non-viral transfection protocols for human chondrocytes became available, but these methods require relatively high cell numbers and cannot be easily adjusted to the analysis of a larger number of samples. The purpose of our work was therefore the establishment of a high-throughput transfection protocol for primary human articular chondrocytes (PHC) that allows the simultaneous transfection of multiple cell samples while reducing the number of cells necessary per experiment. In parallel analogous protocols should be established for the human chondrocytic cell lines T/C-28a2 and HCS-2/8. Methods: Primary human chondrocytes were isolated from adult knee cartilage by an optimized enzymatic digestion protocol and cultivated in high-density monolayer culture for three to five days. T/C-28a2 and HCS-2/8 cells were cultivated under standard conditions. Chondrocytes and chondrocytic cell lines were transfected with an GFP expressing reporter construct applying amaxa's nucleofector and 96-well shuttle devices with experimental variation of transfection parameters, pulse solutions and cell numbers. Transfection efficiencies were measured by FACS and cell viability was determined by an ATP assay. SiRNA constructs targeting GAPDH expression were transfected into the cells using the established nucleofection protocols and mRNA knockdown values were determined by a branched-DNA assay or by quantitative real-time PCR. Results: For high-throughput transfection of primary human chondrocytes transfection efficiencies of more than 70% of surviving cells could be achieved routinely with the presented nucleofection protocol. Cell viability after transfection was around 80%. Transfection efficiency and survival rate were highly dependent on the proper preparation of the PHCs prior to transfection. The cell number used for transfection could be reduced to 2×10 5 per sample in comparison to the established single cuvette protocol. The protocol proved also well suited for the transfer of siRNA molecules to primary human chondrocytes with suppression rates of more than 95% for GAPDH mRNA levels. Transfection efficiencies for T/C-28a2 cells surpassed 90% for both single cuvette and high-throughput formats with survival rates of more than 80%. Single cuvette nucleofection of HCS-2/8 cells reached transfection efficiencies of around 40%.
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Conclusions:
We present the successful adaptation of the nucleofection procedure for primary human chondrocytes to a high-throughput format. The protocol allows the efficient transfection of up to 96 cell samples in parallel and is not limited to the transfection of DNA but can be easily adapted to the transfection of siRNA constructs. The protocol requires substantially lower cell numbers than single cuvette protocols and is therefore very well suited for applications requiring multiple experimental replicates. Likewise, the established protocols for T/C-28a2 cells allow the highly efficient transfection in single cuvette and 96-well formats opening novel application areas. In summary, we present efficient high-throughput transfection protocols for primary human chondrocytes and chondrocytederived cell lines with widespread application potential in osteoarthritis research (siRNA screening assays etc.). Purpose: Population of mesenchymal stem cells (MSC) is formed by subsets which have different capacity of cellular differentiation. This study compares the capacity to repair in vitro chondral defect between the subset of MSC CD271+ and the subset MSC CD271-. Methods: MSC were isolated from bone marrow samples of osteoarthritic patients (n = 4; mean age: 64 years). These cells were characterized by flow cytometry for hematopoietic (CD34 and CD45) and mesenchymal (CD44, CD73, CD90, CD105, CD117 and CD166) markers, and its differentiation potential (adipogenesis, osteogenesis and chondrogenesis) was determined. The MSC were magnetically separated (MACS ® Separation Columns LS, Miltenyi) in two groups: CD271+ and CD271-. In focal defects of articular cartilage (2 mm of diameter) MSC CD271+ or MSC CD271− were deposited. The implants were cultured in chondrogenic differentiation medium supplemented with recombinant human transforming growth factor-beta3 (rHuTGF-beta3) during 8 weeks. The repair tissues were analyzed by histochemical (hematoxilin-eosin and safranin O) and immunohistochemical (types I and II collagens) methods. A semiquantitative histologic scoring system was used to evaluated the repair tissue. The repair percentage was calculated by the formula: (area of neo-synthesized tissue/Area of the original chondral defect) ×100. Results: MSC resulted negative for CD34 and CD45, positive for CD44, CD73, CD90, CD105 and CD166. Furthermore, they showed capacity for chondrogenic, osteogenic and adipogenic differentiation. In both groups of implants, the repair tissue showed morphology like articular cartilage (extracellular matrix with a hyaline aspect and numerous lacunae containing cells of rounded shape), a cellular density higher in repair tissue than in the native cartilage and the expression of types I and II collagens. However, both groups showed differences: the filling of the chondral defect with repair tissue was lower in the implants with MSC CD271− (32.2±9.7%) than in those with MSC CD271+ (59.9±16.6%); safranin O stain of the repair tissue was negative in the implants with CMM CD271− and moderate positive in implants with MSC CD271+; and the integration between the repair tissue and the adjacent normal cartilage resulted of higher quality in the MSC CD271+ implants. Total score was 9.5±0.89 and 12.19±1.01 for implants CD271− and implants CD271+ respectively. Conclusions: Our results indicate that the subset MSC CD271+ brings a chondral repair of higher quality than the subset CD271−. This study was supported by grants from Sergas, Xunta de Galicia PS 07 86. 
AIM:
To analyze whether spheroid methodology is useful to study the chondrogenesis process. To compare the chondrogenesis process using CD-105+ MSC from OA and normal synovium. Methods: Synovial membrane from osteoarthritic cartilage was obtained from patients undergoing total knee arthroplasty. Normal synovial membrane from articular cartilage was obtained from donors who had no history of joint disease. Tissues were digested in a cocktail of collagen/dispase. MSC were seeded in plates and preplating was done to get of rid of fibroblasts. Subpopulation CD-105+ was separated using a magnetic separator (MACS ® Separation Colums LS, Miltenyi) and they were differentiated towards chondrocyte-like cells using a medium with FBS to promote spheroid formation. After two days medium was changed by a chondrogenic medium which was changed every four days. Spheroids were colleted after 14, 24 and 46 days in chondrogenic medium. Spheroids were stained with hematoxylin, eosin and Safranin O or blue alcian to evaluate the distribution of matrix, proteoglycan and aggrecan. Immunohistochemestry studies were carried out to study COL1, COL2 and MMP-13.
Results: Spheroid appears after 7 days in chondrogenic medium. Studies showed no differences between MSC from OA and normal synovial membrane in the chondrogenesis procedure. Intensity of Safranin O was higher at 24 days than at 46 days in culture. It was found the highest intensity in the expression of COL2 after 28 days in culture (100%); meanwhile the expression is lower at 14 and 46 days in culture (60%). COL1 (20−30%) is less intense than COL2 at three times studied, we found the highest expression of COL1 (30%) at 14 days in culture. MMP-13 has its maximum level of intensity (100%) at 46 days in culture. Conclusions: Differentiate chondrocyte-like cells from MSC synovial membrane through spheroid formation is a useful method to study chondrogenesis. No differences between OA and Normal MSC were found in the chondrogenesis process. This work is supported by Xunta de Galicia (SERGAS Exp. PS 07 86).
